Piper Sandler Reiterates Overweight Rating on ESSA Pharma (EPIX)
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren reiterated an Overweight rating and $15.00 price target on ESSA Pharma (NASDAQ: EPIX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
